华大九天：大基金与上海建元减持计划实施完毕

Core Viewpoint - The major shareholders of BGI Genomics (华大九天) have completed their share reduction plans, impacting the company's stock ownership structure [1] Shareholder Reduction Summary - The shareholder known as "Big Fund" reduced its holdings by 2.7147 million shares from September 15 to October 15, representing 0.5% of the total share capital [1] - Shanghai Jianyuan reduced its holdings by 5.4294 million shares from August 13 to October 13, accounting for 1% of the total share capital [1] - Post-reduction, "Big Fund" holds 45.4781 million shares, which is 8.34% of the total share capital, while Shanghai Jianyuan holds 35.7064 million shares, representing 6.55% of the total share capital [1]